Showing 1 - 20 results of 35 for search '(( library based research optimization algorithm ) OR ( binary basic robust detection algorithm ))', query time: 0.59s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    SSA4LSMOP by Zongbin Qiao (19814199)

    Published 2024
    “…<p dir="ltr">SSA4LSMOP is a multi-objective optimization algorithm library, which aims to provide researchers and developers with efficient and easy-to-use multi-objective optimization solutions. …”
  7. 7

    Portable Library for Homomorphic Encrypted Machine Learning on FPGA Accelerated Cloud Cyberinfrastructure by Zhihan Xu (17049357)

    Published 2025
    “…This project will leverage our novel algorithmic, architectural, and memory optimizations on FPGAs to develop a portable library to enable secure and trustworthy ML inference. …”
  8. 8

    Portable Library for Homomorphic Encrypted Machine Learning on FPGA Accelerated Cloud Cyberinfrastructure by Zhihan Xu (17049357)

    Published 2024
    “…This project will leverage our novel algorithmic, architectural, and memory optimizations on FPGAs to develop a portable library to enable secure and trustworthy ML inference. …”
  9. 9

    <b>Portable Library for Homomorphic Encrypted Machine Learning on FPGA Accelerated Cloud Cyberinfrastructure</b> by Zhihan Xu (17049357)

    Published 2023
    “…This project will leverage our novel algorithmic, architectural, and memory optimizations on FPGAs to develop a portable library to enable secure and trustworthy ML inference. …”
  10. 10

    Otago's Network for Engagement and Research: Mapping Academic Expertise and Connections by Sander Zwanenburg (8552102)

    Published 2020
    “…Highlighted staff members can be emailed with the click of a button, allowing to easily bring together people with like-minded research expertise or interests.<br></div><div><br></div><div>In the next stage of the project, we will develop further the data integration schemes, enhance our algorithm to infer expertise based on this data, and update the interactive visualisation to reflect these inferences. …”
  11. 11

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery by Muzammil Kabier (21028487)

    Published 2025
    “…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …”
  12. 12

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery by Muzammil Kabier (21028487)

    Published 2025
    “…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …”
  13. 13

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery by Muzammil Kabier (21028487)

    Published 2025
    “…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …”
  14. 14

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery by Muzammil Kabier (21028487)

    Published 2025
    “…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …”
  15. 15

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery by Muzammil Kabier (21028487)

    Published 2025
    “…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …”
  16. 16

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery by Muzammil Kabier (21028487)

    Published 2025
    “…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …”
  17. 17

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery by Muzammil Kabier (21028487)

    Published 2025
    “…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …”
  18. 18

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery by Muzammil Kabier (21028487)

    Published 2025
    “…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …”
  19. 19

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery by Muzammil Kabier (21028487)

    Published 2025
    “…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …”
  20. 20

    PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery by Muzammil Kabier (21028487)

    Published 2025
    “…The advent of powerful machine learning algorithms as well as the availability of high volume of pharmacological data has given new fuel to QSAR, opening new unprecedented options for deriving highly predictive models for assisting the rationale design of new bioactive compounds, for screening and prioritizing large molecular libraries, and for repurposing new drugs toward new clinical uses. …”